SMAD9 and pulmonary arterial hypertension: A functional study of a missense variant, which was identified in the MH1 DNA binding domain of SMAD9 in a 7-year-old girl with severe PAH, revealed reduced DNA binding and impaired gene activation compared with wt SMAD9 [21].